Literature DB >> 24224425

Valvular calcification, inflammation, and mortality in dialysis patients.

Bonita A Mohamed1, Wei Yang, Harold Litt, Sylvia E Rosas.   

Abstract

BACKGROUND AND AIM OF THE STUDY: The study aim was to determine the correlates of valvular calcification (VC), including clinical and physiologic parameters, in individuals new to dialysis. In addition, the association of VC with coronary artery calcification (CAC) progression and mortality was investigated.
METHODS: A total of 101 incident dialysis individuals underwent electrocardiogram-triggered multislice computed tomography (CT) to monitor the presence and quantification of calcification. The average follow up was 2.85 +/- 0.72 years.
RESULTS: Twenty-six (25.7%) patients had only one valve calcified, while 10 (9.9%) had calcifications in both valves. Patients with VC were older, more likely to have a history of diabetes and/or cardiovascular disease (CVD), more likely to have CAC, and to be Caucasian; fibrinogen and interleukin-6 (IL-6) levels were also higher in these patients. Multivariable Poisson regression analysis revealed older age, history of CVD, increasing fibrinogen, and presence of CAC were independently associated with the presence of VC. Patients with VC also had a higher median annualized CAC progression compared to those without VC (2.90 versus 105.2, p = 0.004). The mortality rate per 100 years was 2.57 in patients without VC, compared to 4.20 and 13.76, respectively, for those with one or two calcified valves. An increasing number of calcified valves was associated with a higher mortality after adjustment for gender and race [HR 2.2 (1.03-4.69), p = 0.04], but was not statistically significant after adjustment for inflammatory markers such as IL-6 or fibrinogen.
CONCLUSION: Traditional and novel risk factors are associated with the presence of VC, which is a risk marker for CAC progression and mortality in incident dialysis patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24224425

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  4 in total

1.  Aortic Artery and Cardiac Valve Calcification are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up.

Authors:  Xiao-Nong Chen; Zi-Jin Chen; Xiao-Bo Ma; Bei Ding; Hua-Wei Ling; Zhong-Wei Shi; Nan Chen
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

2.  High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients.

Authors:  Yenny Kandarini; Gede Wira Mahadita; Sianny Herawati; Ida Bagus Rangga Wibhuti; I Gde Raka Widiana; Nyoman Paramita Ayu
Journal:  Int J Gen Med       Date:  2022-04-20

Review 3.  Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis.

Authors:  Zhe Wang; Aili Jiang; Fang Wei; Haiyan Chen
Journal:  BMC Cardiovasc Disord       Date:  2018-01-25       Impact factor: 2.298

4.  Abdominal aortic calcification is superior to other arteries calcification in predicting the mortality in peritoneal dialysis patients - a 8 years cohort study.

Authors:  Qingyu Niu; Huiping Zhao; Bei Wu; Shihming Tsai; Jian Wu; Meng Zhang; Lixia Lu; Jie Qiao; Chuncui Men; Li Zuo; Mei Wang
Journal:  BMC Nephrol       Date:  2019-12-02       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.